| DAA1031 |
Arthritis (Female) |
Pathological |
cartilage |
Human |
— |
SeriesIncidence |
|
| DAA1030 |
Arthritis (Male) |
Pathological |
cartilage |
Human |
— |
SeriesIncidence |
|
| DAA665 |
Calcification makes cartilage more brittle |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA663 |
Calcification of cartilage matrix |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA801 |
Calcification of costal cartilage |
Physiological |
thorax, cartilage |
Human |
— |
— |
|
| DAA666 |
Cartilage asbestos transformation |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA664 |
Cartilage calcification interferes with normal diffusion metabolism |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA658 |
Cartilage color changes |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA660 |
Cartilage joint surface cracks and frays |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA667 |
Cartilage matrix softening and cavity formation |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA661 |
Cartilage matrix synthesis to degradation ratio decreases |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA671 |
Cartilage resiliency decreases |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA659 |
Cell number decreases in cartilage |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA669 |
Chondroitin sulfate molecules are smaller |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA670 |
Chondroitin sulfate molecules' water-binding capacity is decreased |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA662 |
Fibril types in cartilage matrix are altered |
Physiological |
cartilage |
Human |
— |
— |
|
| DAA668 |
Proteoglycan alterations in cartilage |
Physiological |
cartilage |
Human |
— |
— |
|